Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction | Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Puissance Capital Management LP10 percent owner |
Sell | 1,076,841 @ $0.10 | $111,776 | 0 | 10/13/2023 | 10/16/2023 | |
Puissance Life Science Opportunities Fund VI10 percent owner |
Sell | 134,421 @ $0.83 | $111,569 | 1,076,841 | 06/07/2023 | 06/07/2023 | |
Kim BobaeVP Reg. Affairs & Quality |
Sell | 9,455 @ $10.00 | $94,550 | 1,723 | 05/18/2023 | 05/22/2023 | |
Puissance Life Science Opportunities Fund VI10 percent owner |
Sell | 560,000 @ $9.46 | $5.30 M | 1,211,262 | 05/18/2023 | 05/19/2023 |
Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
---|
A. The list of insiders at Bellerophon Therapeutics, Inc. includes Puissance Capital Management LP.
A. Insiders have sold a total of 1.08 M Bellerophon Therapeutics, Inc. shares in the last 12 months for a total of 111,776 sold.
A. The following insiders have sold Bellerophon Therapeutics, Inc. shares in the last 12 months: Puissance Capital Management LP ($111,776),